Robert Gagnon
Directeur/Bestuurslid bij PURPLE BIOTECH LTD
Vermogen: 192 759 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Eric Rowinsky | M | 67 | 14 jaar | |
| James Green | M | 65 | 9 jaar | |
| Dan Paterson | M | 63 | 13 jaar | |
| Gil Efron | M | 57 | 6 jaar | |
| Daniel Calkins | M | 37 | 6 jaar | |
| Peter Smith | M | - |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
| Caroline Dorsa | F | 64 | 14 jaar | |
| Brian Stuglik | M | 64 | 7 jaar | |
| Jeffrey Frelick | M | 59 | 9 jaar | |
| Michael Kauffman | M | 60 | 12 jaar | |
| Simcha Rock | M | 73 | 11 jaar | |
| Ido Agmon | M | 46 | 8 jaar | |
| Suzana Nahum Zilberberg | F | 53 | 3 jaar | |
| Katherine Eade | F | 50 | 7 jaar | |
| Thomas Loewald | M | 61 | 7 jaar | |
| Michelle Robertson | F | 57 | 3 jaar | |
| Jeffrey A. Duchemin | M | 58 |
KD Scientific, Inc.
 KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | - |
| Isaac Israel | M | 44 | 12 jaar | |
| Bruce Stroever | M | 75 | 12 jaar | |
| Stephen Sherwin | M | 75 | 14 jaar | |
| Anil Kapur | M | 54 | 2 jaar | |
| Ori Hershkovitz | M | 49 | 3 jaar | |
| Paul Bunn | M | 79 | 3 jaar | |
| Yael Margolin | M | 70 | 1 jaar | |
| Lior Fhima | M | - | 2 jaar | |
| Michael Schickler | M | 55 | 4 jaar | |
| Cathy Carew | F | - | - | |
| Bertrand Loy | M | 58 | 10 jaar | |
| John Johnson | M | 66 | 4 jaar | |
| Siddhesh Angle | M | 39 | - | |
| Kristina Burrow | F | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
| Michael Rome | M | 39 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
| Michael Rome | M | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
| Ido Morpurgo | M | 51 | 4 jaar | |
| Michael Dambach | M | 57 | 17 jaar | |
| Hagop Youssoufian | M | 67 | 7 jaar | |
| Karin Tollefson | M | 57 | 1 jaar | |
| Yisrael Gewirtz | M | 47 | 8 jaar | |
| Deina Walsh | F | 60 | 10 jaar | |
| William Berlin | M | - | - | |
| Scott Biller | M | 68 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 4 jaar |
| Jonathan Pachter | M | 66 | 13 jaar | |
| David Mitchell | M | 67 | 1 jaar | |
| Don Hankey | M | 81 | 6 jaar | |
| Leon E. Chen | M | 49 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
| Hadas Reuveni | M | 56 | 7 jaar | |
| Bertrand C. Liang | M | 61 | 4 jaar | |
| J. Goater | M | 48 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 1 jaar |
| Matt Patterson | M | 52 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 3 jaar |
| Michael Crowther | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 84 | 84.00% |
| Israël | 17 | 17.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Robert Gagnon
- Persoonlijk netwerk
